Antigen Recognition and Allogeneic Tumor Rejection in CD8+ TCR Transgenic/RAG-/- Mice

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4665-4675

  Manning, Thomas C ^a   Rund, Laurie A ^a   Gruber, Meegan M ^a   Fallarino, Francesca ^b   Gajewski, Thomas F ^b   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DBA MOUSE; GENE; GENETICS; GRAFT REJECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; SARCOMA; TRANSGENIC MOUSE; TUMOR ESCAPE; TUMOR RECURRENCE;

ANIMALS; ANTIGENS, CD80; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GENES, RAG-1; GRAFT REJECTION; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

EID: 0031573215     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Auchincloss, J. H., and D. H. Sachs. 1993. Transplantation and graft rejection. In Fundamental Immunology. W. E. Paul. Raven Press, New York, p. 1109.
2. Huang, A. Y. C., P. Golumbeck, M. Ahmadzadeh, E. Jaffee, D. Pardol, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
3. Huang, A. Y. C., A. T. Bruce, D. M. Pardol, and H. I. Levitsky. 1996. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med. 183:769.
4. Lee, R. S., M. J. Grusby, L. H. Glimcher, H. J. Winn, and H. Auchincloss, Jr. 1994. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179:865.
5. Auchincloss, J., H., R. R. M. Ghobrial, P. S. Russell, and H. J. Winn. 1988. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation 45:1118.
6. Schilham, M. W., W.-P. Fung-Leung, A. Rahemtulla, T. Kundig, L. Zhang, J. Potter, R. G. Miller, H. Hengartner, and T. W. Mak. 1993. Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur. J. Immunol. 23:1299.
7. + cells are essential for allorejection. J. Exp. Med. 184:2013.
8. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
9. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
10. Reiser, H., and M. J. Stadecker. 1996. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune disease. N. Engl. J. Med. 335:1369.
11. Sperling, A. I., J. A. Auger, B. D. Ehst, I. C. Rulifson, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.
12. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
13. Lenschow, D. J., Y. Zeng, J. R. Thistlewaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
14. Pearson, T. C., D. Z. Alexander, K. J. Winn, P. S. Linsley, R. P. Lowry, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701.
15. Woodward, J. E., L. Qin, K. D. Chavin, J. Lin, T. Tono, Y. Ding, P. S. Linsley, J. S. Bromberg, and P. Baliga. 1996. Blockade of multiple costimulatory receptors induces hyporesponsiveness. Transplantation 62:1011.
16. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059.
17. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
18. Kawai, K., A. Shahinian, T. W. Mak, and P. S. Oshashi. 1996. Skin allograft rejection in CD28-deficient mice. Transplantation 61:352.
19. Kundig, T. M., A. Shahinian, K. Kawai, H.-W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41.
20. Kranz, D. M., D. H. Sherman, M. V. Sitkovsky, M. S. Pasternack, and H. N. Eisen. 1984. Immunoprecipitation of cell surface structure of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc. Natl. Acad. Sci. USA 81:573.
21. Sykulev, Y., A. Brunmark, M. Jackson, R. J. Cohen, P. A. Peterson, and H. N. Eisen. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1:15.
22. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβ T cell receptor structure at 2.5 angstrom and its orientation in the TCR-MHC complex. Science 274:209.
23. Udaka, K., K. Wiesmuller, S. Kienle, G. Jung, and P. Walden. 1996. Self-MHC-restricted peptides recognized by and alloreactive T-lymphocyte clone. J. Immunol. 157:670.
24. Tallquist, M. D., T. J. Yun, and L. R. Pease. 1996. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184:1017.
25. Schodin, B. A., T. J. Tsomides, and D. M. Kranz. 1996. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity 5:137.
26. Kranz, D. M., S. Tonegawa, and H. N. Eisen. 1984. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 81:7922.
27. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271.
28. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73.
29. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869.
30. Dunn, Y. B., and M. J. Potter. 1957. A transplantable mast-cell neoplasm in the mouse. J. Natl. Cancer Inst. 18:587.
31. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellstrom, and K. E. Hellstrom. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523.
32. Gajewski, T. F., F. Fallarino, C. Uyttenhove, and T. Boon. 1996. Tumor rejection requires a CTLA-4 ligand provided by the host or expressed on the tumor. J. Immunol. 156:2909.
33. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156:465.
34. Shinkai, Y., G. Rathbun, K.-P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855.
35. Alexander, J., J. A. Payne, R. Murray, J. A. Frelinger, and P. Cresswell. 1989. Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics 29:380.
36. d antigen, the product of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125: 2473.
37. Uyttenhove, C., J. Van Snick, and T. Boon. 1980. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J. Exp. Med. 152:1175.
38. + cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69:989.
39. Sykulev, Y., A. Brunmark, T. J. Tsomides, S. Kageyama, M. Jackson, P. A. Peterson, and H. N. Eisen. 1994. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91:11487.
40. Thomsen, A. R., J. Johansen, O. Marker, and J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient and B-cell deficient mice. J. Immunol. 157: 3074.
41. + murine T cells. Immunol. Res. 13:215.
42. Kelly, K. A., H. Pircher, H. von Boehmer, M. M. Davis, and R. Scollay. 1993. Regulation of T cell production in T cell receptor transgenic mice. Eur. J. Immunol. 23:1922.
43. + T cells in vitro. J. Exp. Med. 183:2247.
44. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
45. Kos, F. J., and E. G. Engleman. 1995. Requirement for natural killer cells in the induction of cytotoxic T cells. J. Immunol. 155:578.
46. Hunter, C. A., R. Chizzonite, and J. S. Remington. 1995. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells. J. Immunol. 155:4347.
47. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579.
48. Ybarrondo, B., A. M. O'Rourke, A. A. Brian, and M. F. Mescher. 1994. Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation. J Exp. Med. 179:359.
49. Lucas, P. J., I. Negishi, K. Nakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
50. + T cells. J. Immunol. 158:637.
51. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
52. + T cell-deficient mice. J. Virol. 68:4700.
53. + T cells. Eur. J. Immunol. 27:598.
54. Pace, J. L., S. W. Russell, B. A. Torres, H. M. Johnson, and P. W. Gray. 1983. Recombinant mouse γ interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130:2011.
55. Holter, W., R. Grunow, H. Stockinger, and W. Knapp. 1986. Recombinant interferon-γ induces interleukin 2 receptors on human peripheral blood monocytes. J. Immunol. 136:2171.
56. Frey, A. B. 1996. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762. J. Immunol. 156:3841.
57. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271.
58. Rulifson, I. C., A. I. Sperling, P. E. Fields, F. W. Fitch, and J. A. Bluestone. 1997. CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158: 658.
59. Dutton, R. W. 1996. The regulation of the development of CD8 effector T cells. J. Immunol. 157:4287.
60. Carter, L. L., and R. W. Dutton. 1995. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J. Immunol. 144:1028.
61. + T cells to mount primary proliferative and cytotoxic responses to Ia tumor cells. Nature 322:141.
62. Bassiri, H., J. Markmann, F., N. M. Desai, J. I. Kim, H.-S. Teh, and C. F. Barker. 1993. Allograft rejection by T cell receptor transgenic mice. J. Surg. Res. 54:437.
63. + T cells tolerized in vivo. J. Immunol. 157:4297.
64. Zhang, L. 1996. The fate of adoptively transferred antigen-specific T cells in vivo. Eur. J. Immunol. 26:2208.